Mark van Ooij

Mark van Ooij is scientific director, Johnson & Johnson Innovative Medicine, Leiden, The Netherlands.

Articles by Mark van Ooij

Erledigte Aufgaben werden auf einer To-Do-Liste abgehakt | Image Credit: © Ralf Geithe - Stock.Adobe.com

This study reviews changes in in-country testing (registration testing, import testing) requirements and analyzes current trends. In the context of international harmonization of good practices and standards as well as the improved information exchange between national regulatory authorities, in-country testing is considered outdated and redundant in many cases.